🇺🇸 FDA
Patent

US 12296047

Manufacturing of bupivacaine multivesicular liposomes

granted A61KA61K31/451A61K9/1277

Quick answer

US patent 12296047 (Manufacturing of bupivacaine multivesicular liposomes) held by Pacira Pharmaceuticals, Inc. expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Pacira Pharmaceuticals, Inc.
Grant date
Tue May 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K31/451, A61K9/1277